Key Dates

  • Cut-off Date for Voting Eligibility: Friday, June 05, 2026
  • Remote e-Voting Start: Tuesday, June 16, 2026, at 09:00 AM IST
  • Remote e-Voting End: Wednesday, July 15, 2026, at 05:00 PM IST
  • Result Declaration: On or before Friday, July 17, 2026

Parties Involved

  • Registrar and Transfer Agent (RTA): M/s. MUFG Intime India Private Limited (formerly Link Intime India Private Limited)
  • E-Voting Service Provider: National Securities Depository Limited (NSDL)
  • Scrutinizer: M/s. Mittal V Kothari & Associates, Practicing Company Secretaries, Ahmedabad
  • Stock Exchange: BSE Limited (BSE SME Platform)

Agenda Items and Resolutions

Item No. 1: Appointment of Ms. Smita Kiran Davda as Non-Executive Independent Director

  • Resolution Type: Special Resolution
  • Director Details: Ms. Smita Kiran Davda (DIN: 11125469)
  • Appointment Term: 5 consecutive years from June 13, 2026, to June 12, 2031
  • Current Status: Appointed as an Additional Director (Non-Executive Independent) effective June 13, 2026, holding office till the ensuing General Meeting or 3 months.
  • Qualifications: Chartered Accountant, Masters of Commerce, Advanced Program in Fintech and Financial Blockchain from IIM Calcutta.
  • Expertise: Banking, finance, risk management, and corporate governance. Previously held senior positions at Yes Bank Limited.
  • Other Directorships: Serves as an Independent Director on the board of Rayzon Solar Limited, Surat (Member of its Audit Committee and Nomination and Remuneration Committee).
  • Remuneration: To be paid sitting fees for attending Board and Committee meetings as recommended by the Nomination and Remuneration Committee (NRC) and approved by the Board, plus reimbursement of expenses.
  • Shareholding: Holds NIL shares in the company.

Item No. 2: Appointment of Mr. Sachin Bhandari as Non-Executive Independent Director

  • Resolution Type: Special Resolution
  • Director Details: Mr. Sachin Bhandari (DIN: 11768182)
  • Appointment Term: 5 consecutive years from June 13, 2026, to June 12, 2031
  • Current Status: Appointed as an Additional Director (Non-Executive Independent) effective June 13, 2026 (or date of obtaining valid DIN, whichever is later), holding office till the ensuing General Meeting or 3 months.
  • Qualifications: Master of Business Administration (MBA), Bachelor of Commerce (B.Com).
  • Expertise: Over 25 years in the pharmaceutical industry with expertise in quality systems, regulatory compliance, digital transformation, and risk management. Held senior positions at UCB Pharma, Boehringer Ingelheim, Sun Pharmaceutical Industries, Reckitt Benckiser, and GSK.
  • Other Directorships: None disclosed.
  • Remuneration: To be paid sitting fees for attending Board and Committee meetings as recommended by the NRC and approved by the Board, plus reimbursement of expenses.
  • Shareholding: Holds NIL shares in the company.

Item No. 3: Migration of Listing from BSE SME to Main Boards of BSE and NSE

  • Resolution Type: Special Resolution
  • Condition for Approval: As per SEBI ICDR Regulation 277, the resolution shall be acted upon only if votes cast by shareholders (other than promoters) in favour are at least two times the votes cast against.
  • Current Listing: Equity shares (Face Value: Rs. 10.00) are listed on the BSE SME Platform since October 10, 2022.
  • Proposed Listing: Migration to the Main Board of BSE Limited and the Main Board of National Stock Exchange of India Limited (NSE).
  • Rationale: Cited reasons include steady growth, enhanced transparency, improved governance, robust internal controls, strengthened compliance, a scalable business model, and the expectation of greater visibility, improved liquidity, and wider investor participation.
  • Eligibility: The company has completed the minimum period of three years from its listing date (Oct 2022) as required by SEBI ICDR Regulations for migration.
  • Approvals Required: Subject to shareholder approval and subsequent approvals from BSE, NSE, and other regulatory authorities.

Voting Process Details

  • Mode of Voting: Remote e-voting only; no physical ballot forms are being sent.
  • E-Voting Platform: Provided by National Securities Depository Limited (NSDL).
  • Eligibility: Members holding shares as of the cut-off date (June 05, 2026).
  • Voting Rights: One vote per equity share. For joint holders, only the first-named holder can vote.
  • Scrutinizer: M/s. Mittal V Kothari & Associates appointed to scrutinize the e-voting process.
  • Result Publication: Results and the Scrutinizer's report will be placed on the company's website (www.tridentlifeline.com), NSDL's e-voting website (www.evoting.nsdl.com), and communicated to BSE.

Financial Impact

Financial impact not quantified in the disclosure for any agenda item. The director appointments will result in outflow towards sitting fees and expense reimbursements, but the amount is not specified. The migration process may involve costs related to regulatory compliance and listing fees, but these are not quantified.

Capital Structure Impact

No direct impact on the capital structure from the director appointments. The migration resolution pertains only to the trading platform of existing equity shares and does not involve any issuance or change in share capital.

Governance and Compliance

  • The notice is issued in compliance with SEBI LODR Regulations, the Companies Act, 2013, and various MCA Circulars.
  • Both proposed directors have submitted declarations of independence as per Section 149(6) of the Companies Act and Regulation 16(1)(b) of SEBI LODR.
  • The company has received notices under Section 160 of the Companies Act from a member proposing the candidature of both directors.